
Join to view full profile
543 Taylor AveColumbus, OH 43203
Phone+1 614-293-4837
Fax+1 614-293-3125
Dr. Rovin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1989 - 1989
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1986
University of Illinois College of MedicineClass of 1983
Certifications & Licensure
OH State Medical License 1990 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- Complement inhibitors and B cell-modifying agents for IgA nephropathy-a Kidney Disease: Improving Global Outcomes (KDIGO) commentary.Brad H Rovin, Jonathan Barratt, H Terence Cook, Irene L Noronha, Heather N Reich
Kidney International. 2026-09-01 - Targeting B cells in immune-mediated kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.Jürgen Floege, Isabelle Ayoub, Silke R Brix, Kirk N Campbell, Richard Furie
Kidney International. 2026-09-01 - A population-scale transcriptional atlas of blood and tissue in lupus nephritis.Nicholas W Sugiarto, Siddarth Gurajala, Michelle Curtis, Thomas M Eisenhaure, Arnon Arazi
Science Translational Medicine. 2026-08-19
Journal Articles
- Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, The New England Journal of Medicine
- A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Dose-Ranging Voclosporin with Placebo in Achieving Remission in Patients with Active L...Brad H Rovin, William F Pendergraft, Kidney International
- Peripheral Blood B Cell Depletion After Rituximab and Complete Response in Lupus NephritisMatthew D Cascino, Jay Garg, Paul Brunetta, Tamiko R Katsumoto, Paul Brakeman, Brad Rovin, Leonard Dragone, Richard John Looney, Journal of the American Society of Nephrology
Lectures
- Case Studies in Glomerular DiseaseAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
- A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance TherapyAmerican Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019
Other
- A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance TherapyBrad Rovin, MD, Kidney International
https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
UpToDate, Wolters Kluwer Health - 2013-01-03 - A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance TherapyBrad Rovin, MD, Kidney International
https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
UpToDate, Wolters Kluwer Health - 2013-01-24 - A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance TherapyBrad Rovin, MD, Kidney International
https://www.doximity.com/articles/f57e0281-b555-4e34-9cc9-02fdf46f5ce7
UpToDate, Wolters Kluwer Health - 2013-03-06
Press Mentions
National Kidney Foundation 2026 Awards and HonorsApril 28th, 2026
ACR 2025: Key Highlights in Systemic Lupus and Lupus NephritisNovember 4th, 2025
KDIGO Issues New Guideline for Managing IgAN and IgAVOctober 6th, 2025
Grant Support
- Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
- Muscle-Kidney Crosstalk in Age-related Kidney DiseaseOHIO STATE UNIVERSITY2020–2026
- Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis CureOHIO STATE UNIVERSITY2022–2025
- Forecasters Of Futute And Progressive CDK In Patients With Microvascular GlomerulNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









